Brintellix Not Roaring Out Of The Gate

Quote

Anonymous

Guest
Brintellix Not Roaring Out Of The Gate

It's much too early to call Brintellix's launch a failure, but given the challenges of launching a new depression drug into a market loaded with generic options, investors aren't going to be exceedingly patient. Sampling seems to have had some impact on reported sales, but Brintellix seems to be tracking around 60% to 80% of Forest Labs' (FRX) Viibryd launch.

At this point, Brintellix is being positioned later in treatment than management had hoped (meaning that doctors try a larger number of other drugs before going to Brintellix). This is an area where marketing can help, but it's worth remembering that Lundbeck has only just put together its U.S. sales force and partner Takeda has no previously experience in this therapeutic area.

A few drivers can improve Brintellix from here. First, Takeda and Lundbeck can get their feet under them, gain experience, and improve their marketing efforts and efficacy. Just as important, there will be additional data coming out on Brintellix, data that can support a better label and real differentiation in the market on the basis of more benign side effects (like sexual dysfunction).
 








Well, management can start by not lying to us for one. We were told that we would have the psychs and they would have to primary care. Well, it was half true. We do have psychs, but so do they. We were told we would get full credit for all Brintellix Rx's written in our territory. That was another lie. Sales data is obviously a joke. The savings card is better, but not very competitive. Managed care is horrible. The market is totally controlled by generics. Takeda is insane and runs the show. This has all the makings of a disaster.
 




Anonymous said:
Well, management can start by not lying to us for one. We were told that we would have the psychs and they would have to primary care. Well, it was half true. We do have psychs, but so do they. We were told we would get full credit for all Brintellix Rx's written in our territory. That was another lie. Sales data is obviously a joke. The savings card is better, but not very competitive. Managed care is horrible. The market is totally controlled by generics. Takeda is insane and runs the show. This has all the makings of a disaster.
Click to expand...

Scarey!!!!Takeda marketing running the show,with their track record of failure of every drug they have launched since 2010!!Doomed for failure!Great entertainment,watching Takeda marketing launch a drug!
 




Take a look at those in charge calling the shots. Ask yourself, what did they sell as reps? If the answer is Actos then you'll understand the clusterf*ck we are now in. The "geniuses" calling the shits are the same "selling superstars" who drove Actos share to number 2 in the TZD market.....in a two drug field. They never learned how to sell, they just hung around long enough to wait for talented people to leave and then they filled the slots with crap. The only reason most of current management is here is that they know they could never get the same position outside of Takeda. How could they expect to compete with talent from other companies when all they can say is they sold 1 product that competed, and failed, against 1 other product? We are in the shape we are in due to the lack of leadership, experience, and talent at the higher level. Get out while you still can and beat the next wave of layoffs coming soon!
 




Anonymous said:
Take a look at those in charge calling the shots. Ask yourself, what did they sell as reps? If the answer is Actos then you'll understand the clusterf*ck we are now in. The "geniuses" calling the shits are the same "selling superstars" who drove Actos share to number 2 in the TZD market.....in a two drug field. They never learned how to sell, they just hung around long enough to wait for talented people to leave and then they filled the slots with crap. The only reason most of current management is here is that they know they could never get the same position outside of Takeda. How could they expect to compete with talent from other companies when all they can say is they sold 1 product that competed, and failed, against 1 other product? We are in the shape we are in due to the lack of leadership, experience, and talent at the higher level. Get out while you still can and beat the next wave of layoffs coming soon!
Click to expand...

Best Post Ever!
 




Anonymous said:
Take a look at those in charge calling the shots. Ask yourself, what did they sell as reps? If the answer is Actos then you'll understand the clusterf*ck we are now in. The "geniuses" calling the shits are the same "selling superstars" who drove Actos share to number 2 in the TZD market.....in a two drug field. They never learned how to sell, they just hung around long enough to wait for talented people to leave and then they filled the slots with crap. The only reason most of current management is here is that they know they could never get the same position outside of Takeda. How could they expect to compete with talent from other companies when all they can say is they sold 1 product that competed, and failed, against 1 other product? We are in the shape we are in due to the lack of leadership, experience, and talent at the higher level. Get out while you still can and beat the next wave of layoffs coming soon!
Click to expand...

That sounds like you are referring to Mark?
 












When you have management that tell reps: We have alot of Brintellix samples available. If the doctor is on the fence, give him a case.
Yea that'll do it.... What a dumb ass.
 




















Anonymous said:
Take a look at those in charge calling the shots. Ask yourself, what did they sell as reps? If the answer is Actos then you'll understand the clusterf*ck we are now in. The "geniuses" calling the shits are the same "selling superstars" who drove Actos share to number 2 in the TZD market.....in a two drug field. They never learned how to sell, they just hung around long enough to wait for talented people to leave and then they filled the slots with crap. The only reason most of current management is here is that they know they could never get the same position outside of Takeda. How could they expect to compete with talent from other companies when all they can say is they sold 1 product that competed, and failed, against 1 other product? We are in the shape we are in due to the lack of leadership, experience, and talent at the higher level. Get out while you still can and beat the next wave of layoffs coming soon!
Click to expand...

everyone should read this.....particularly those HQ douches
 








You big dumb Fuk, how many antidepressants have been launched since 2011? You are so Fn stupid, drink some more Kool Aid you dik wad. You, as sperm should have been swallowed instead of inseminated. You are that stupid.
 




Takeda has 0 commitment to Brintellix. Hell, we have THE worst copay card in the business. They won't even match Viibyrd's copay card. That shows they don't give a shit about the drug. This drug is done.
 








This company is so unprofessional! I have never worked with such two-faced back biting teammates. The committment to Brintellix is non-exist - the copay card is a joke and the placement is awful!!! I hate it here and I hate my team-mates. They try to steal all credit and any docs who are writing they try to split! The other products are second rate as well - even if the "new" diet drug is being written it won't last. Generics all the way
 




Top Bottom
Back
Quote